Lv3
230 积分 2026-05-12 加入
THE PRECLINICAL JOURNEY OF MET INHIBITORS
3天前
已完结
CASE HISTORY: DISCOVERY AND DEVELOPMENT OF VERQUVO® (VERICIGUAT), A SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATOR FOR THE TREATMENT OF CHRONIC HEART FAILURE
3天前
已完结
CASE HISTORY: NURTEC® ODT (RIMEGEPANT) FOR THE ACUTE AND PREVENTIVE TREATMENT OF MIGRAINE
3天前
待确认
CASE HISTORY: CORECTIM® (DELGOCITINIB), THE FIRST TOPICAL JAK INHIBITOR FOR THE TREATMENT OF ATOPIC DERMATITIS
3天前
已完结
CASE HISTORY: THE DISCOVERY OF KRAZATI®(ADAGRASIB) FOR THE TREATMENT OF KRASG12C-MUTATED LUNG CANCER
3天前
已完结
The value of coimmunoprecipitation (Co-IP) assays in drug discovery
5天前
已完结
Affinity selection mass spectrometry (AS-MS) as a tool to accelerate drug discovery efforts
6天前
已完结
Momelotinib – a tale of trials, tribulations, transfusion independence, and triumph
6天前
已完结
Understanding drug-target residence time and the implications on drug discovery
6天前
已完结
CASE HISTORY: DISCOVERY AND DEVELOPMENT OF THE PI3Kδ-SELECTIVE INHIBITOR JOENJA ® (LENIOLISIB, CDZ173) AS A TARGETED THERAPY FOR PATIENTS WITH ACTIVATED PI3Kδ SYNDROME (APDS)
9天前
已完结
Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine
2天前
已采纳
Stereoretentive decarbonylative C(sp3)-C(sp3) cross-coupling
5天前
已采纳
Stereoretentive decarbonylative C(sp3)-C(sp3) cross-coupling
5天前
已采纳
USAG-1 aggravates renal ischemia‒reperfusion injury via promoting GPX4 degradation-induced ferroptosis
5天前
已采纳
Morphological diversification and functional maturation of human astrocytes in glia-enriched cortical organoid transplanted in mouse brain
5天前
已采纳
Policy synergies outweigh trade-offs for NH3 and N2O co-control in China
5天前
已采纳
Multiplexed inhibition of immunosuppressive genes with Cas13d for on-demand combinatorial cancer immunotherapy
5天前
已采纳
Autonomous navigation of intelligent microrobotic swarms in unknown environments
5天前
已采纳
Acute kidney injury
5天前
已采纳
Polychromatic Circularly Polarized Luminescence Enhanced Multi‐Dimensional Encryption
5天前
已采纳
皖公网安备34019202002308
